Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             77 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute psychological and physiological effects of MDMA (“Ecstasy”) after haloperidol pretreatment in healthy humans Liechti, Matthias E.
 2000
 10 Supplement 3 p. 289-295
7 p.
 artikel
2 Adverse effects of the comedication of neuroleptics and antidepressants Grohmann, R.
 2000
 10 Supplement 3 p. 112-113
2 p.
 artikel
3 Allosteric modulation of adenosine receptors Ijzerman, A.P.
 2000
 10 Supplement 3 p. 214-215
2 p.
 artikel
4 Altered brain protein kinase C in depression: a post-mortem study Coull, Moyra A.
 2000
 10 Supplement 3 p. 283-288
6 p.
 artikel
5 An overview of the efficacy and safety of rapid-acting intramuscular ziprasidone Daniel, D.G.
 2000
 10 Supplement 3 p. 289-
1 p.
 artikel
6 Antidepressant associated suicidality Healy, D.
 2000
 10 Supplement 3 p. 260-
1 p.
 artikel
7 Anxiolysis associated with antidepressant response to bupropion sustained release or sertraline Rush, A.J.
 2000
 10 Supplement 3 p. 236-
1 p.
 artikel
8 A placebo-controlled, double-blind study of pregabalin treatment of social phobia: Outcome and predictors of response Feltner, D.E.
 2000
 10 Supplement 3 p. 344-345
2 p.
 artikel
9 Asperger's disorder in the emergency psychiatric setting Raja, M.
 2000
 10 Supplement 3 p. 385-386
2 p.
 artikel
10 A 3-week, double-blind, randomized trial of ziprasidone in the acute treatment of mania Keck Jr., P.E.
 2000
 10 Supplement 3 p. 297-
1 p.
 artikel
11 Brain lithium measurements with 7Li magnetic resonance spectroscopy (MRS): a literature review Soares, Jair C
 2000
 10 Supplement 3 p. 151-158
8 p.
 artikel
12 cAMP signalling system in the pharmacotherapy and pathophysiology of bipolar disorder Perez, J.
 2000
 10 Supplement 3 p. 143-
1 p.
 artikel
13 Cerebrospinal fluid tau phosphorylated at threonine 231 compared to total tau in Alzheimer's disease patients, controls, and subjects at risk Bürger, K.
 2000
 10 Supplement 3 p. 371-
1 p.
 artikel
14 Change over time in psychological distress of inpatients with severe mental disorders Ritsner, M.
 2000
 10 Supplement 3 p. 397-
1 p.
 artikel
15 Changes of ANP plasma concentrations in alcoholics during withdawal Kiefer, F.
 2000
 10 Supplement 3 p. 378-
1 p.
 artikel
16 Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment Bäckman, Jakob
 2000
 10 Supplement 3 p. 341-349
9 p.
 artikel
17 Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: an in vivo microiontophoretic study Gobbi, Gabriella
 1999
 10 Supplement 3 p. 43-49
7 p.
 artikel
18 Clozapine plasma levels and time to clinical response in a standardized trial La Pia, S.
 2000
 10 Supplement 3 p. 307-308
2 p.
 artikel
19 Cognitive and sleep effects of antihistamines: Human studies Alford, C.
 2000
 10 Supplement 3 p. 202-203
2 p.
 artikel
20 Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults Philipp, M.
 2000
 10 Supplement 3 p. 305-314
10 p.
 artikel
21 Contrasting effects of typical and atypical antipsychotics on neuronal viability and functioning of the anterior cingulate region in chronic schizophrenia: A MRSI study Braus, D.F.
 2000
 10 Supplement 3 p. 285-286
2 p.
 artikel
22 Coping-orientated treatment and atypical neuroleptics in an integrated treatment approach for patients with schizophrenia Schaub, A.
 2000
 10 Supplement 3 p. 327-
1 p.
 artikel
23 Decreased GSK-3̵ immunoreactivity in postmortem frotal cortex of schizophrenic patients Kozlovsky, N.
 2000
 10 Supplement 3 p. 333-
1 p.
 artikel
24 Depression, disability and service use in primary health care in six countries Herrman, H.
 2000
 10 Supplement 3 p. 228-
1 p.
 artikel
25 Differential actions of the new antipsychotic agents Moore, N.A.
 2000
 10 Supplement 3 p. 321-322
2 p.
 artikel
26 Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice Alvarez, Jean-Claude
 1999
 10 Supplement 3 p. 31-36
6 p.
 artikel
27 Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms and the pro-/anti-inflammatory cytokine balance Kelly, J.P.
 2000
 10 Supplement 3 p. 278-279
2 p.
 artikel
28 Dimensions of psychopathology in schizophrenia: a factor analysis of the amisulpride database Rein, W.
 2000
 10 Supplement 3 p. 315-
1 p.
 artikel
29 Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients Scharfetter, Joachim
 1999
 10 Supplement 3 p. 17-20
4 p.
 artikel
30 Dose-dependent enhancement of cognitive performance in young volunteers following single doses of Ginkgo biloba Kennedy, D.
 2000
 10 Supplement 3 p. 391-
1 p.
 artikel
31 DU 127090: a highly potent, atypical dopamine receptor ligand — high potency but low efficacy at dopamine D2 receptors in vitro Van Vliet, B.J.
 2000
 10 Supplement 3 p. 294-
1 p.
 artikel
32 Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain Brambilla, A.
 1999
 10 Supplement 3 p. 63-67
5 p.
 artikel
33 Effects of donepezil on behaviour and other domains in moderate to severe Alzheimer's disease Gauthier, S.
 2000
 10 Supplement 3 p. 359-360
2 p.
 artikel
34 Efficacy and safety of donepezil in patients with Alzheimer's disease: preliminary findings from the Australian subset of a global clinical experience study Brodaty, H.
 2000
 10 Supplement 3 p. 367-
1 p.
 artikel
35 Efficacy and tolerability of mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholia Guelfi, J.D.
 2000
 10 Supplement 3 p. 266-
1 p.
 artikel
36 Evidence for an association between a G-protein-β3-gene variant with depression and response to antidepressant treatment Zill, P.
 2000
 10 Supplement 3 p. 253-
1 p.
 artikel
37 Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia Gothelf, Doron
 2000
 10 Supplement 3 p. 389-395
7 p.
 artikel
38 fMRI in normal functioning and psychiatric disorders Gabrieli, J.D.E.
 2000
 10 Supplement 3 p. 179-180
2 p.
 artikel
39 Functional repair of global and focal ischaemic brain damage by grafts of conditionally immortal neuroepithelial stem cells Gray, J.A.
 2000
 10 Supplement 3 p. 153-154
2 p.
 artikel
40 Haptoglobin phenotypes and genotypes in schizophrenia Maes, M.
 2000
 10 Supplement 3 p. 333-
1 p.
 artikel
41 1H-MR-Spectroscopy of untreated depressive patients shows reduced N-acetyl aspartate, choline and myo-inositol levels in the frontal lobe Frey, R.
 2000
 10 Supplement 3 p. 280-
1 p.
 artikel
42 Humoral component of regeneration and learning is a subcase of neurosecretion Sapronov, N.S.
 2000
 10 Supplement 3 p. 384-
1 p.
 artikel
43 Impact of early intervention with intramuscular antipsychotic medication in an acute care setting Martinez, J.M.
 2000
 10 Supplement 3 p. 295-
1 p.
 artikel
44 Impact of olanzapine added to lithium or valproate on the quality of life of patients with bipolar disorder Namjoshi, M.
 2000
 10 Supplement 3 p. 247-
1 p.
 artikel
45 Improvement of CCK-4 induced panic by selective GABA-transaminase-inhibition with vigabatrin Zwanzger, P.
 2000
 10 Supplement 3 p. 339-
1 p.
 artikel
46 Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study Loonen, A.J.M.
 1999
 10 Supplement 3 p. 51-57
7 p.
 artikel
47 Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study Rogers, S.L
 2000
 10 Supplement 3 p. 195-203
9 p.
 artikel
48 Maladaptation to stress in schizophrenia Gispen-de Wied, C.C.
 2000
 10 Supplement 3 p. 163-164
2 p.
 artikel
49 Microdialysis in parkinsonian patient basal ganglia: apomorphine effect without changes in the release of neuroactive amino acids Fedele, E.
 2000
 10 Supplement 3 p. 366-
1 p.
 artikel
50 Mirtazapine and the onset of antidepressant action: survival function analysis-response Nierenberg, A.A.
 2000
 10 Supplement 3 p. 265-
1 p.
 artikel
51 Molecular modeling of the GABAB receptor subdomains: Two putative binding sites in allosteric interaction? Bernard, P.
 2000
 10 Supplement 3 p. 212-213
2 p.
 artikel
52 Nicotine modulates nitric oxide in rat brain Pogun, Sakire
 2000
 10 Supplement 3 p. 463-472
10 p.
 artikel
53 No differences in inositol monophosphatase activity and GSK-3β immunoreactivity between bipolar patients and normal controls in postmortem brain Agam, G.
 2000
 10 Supplement 3 p. 142-143
2 p.
 artikel
54 Novelty seeking and harm avoidance and dopamine 4 and serotonine 2A receptor gene polymorphisms Schüssler, P.
 2000
 10 Supplement 3 p. 398-
1 p.
 artikel
55 Opposing changes in serotonin and norepinephrine transporter mRNA levels after serotonin depletion Koed, Karen
 2000
 10 Supplement 3 p. 501-509
9 p.
 artikel
56 Oral administration of losartan influences aminopeptidase activity in the frontal cortex Prieto, Isabel
 2000
 10 Supplement 3 p. 279-282
4 p.
 artikel
57 Pindolol can be effectively given once or twice daily for augmentation in psychiatric patients Koch, H.J.
 2000
 10 Supplement 3 p. 511-512
2 p.
 artikel
58 Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid Richardson, A.J
 2000
 10 Supplement 3 p. 189-193
5 p.
 artikel
59 Risperidone is more useful than bromperidol in the treatment of first-episode schizophrenic patients Suhiyoshi, A.
 2000
 10 Supplement 3 p. 332-
1 p.
 artikel
60 Short term and long term effects of venlafaxine and trimipramine on cognitive psychomotor performance in patients with major depression Hemmeter, U.
 2000
 10 Supplement 3 p. 243-
1 p.
 artikel
61 SSRIs in the treatment of premenstrual dysphoric disorder. Nefazodone: An open trial Pallanti, S.
 2000
 10 Supplement 3 p. 127-128
2 p.
 artikel
62 Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine Weigmann, Harald
 2000
 10 Supplement 3 p. 401-405
5 p.
 artikel
63 Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis Dremencov, Eliyahu
 2000
 10 Supplement 3 p. 229-236
8 p.
 artikel
64 Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors Rehavi, Moshe
 2000
 10 Supplement 3 p. 145-150
6 p.
 artikel
65 Symptom relief obtained with Venlafaxine versus fluoxetine in depressed patients with concomitant anxiety De Nayer, A.
 2000
 10 Supplement 3 p. 242-
1 p.
 artikel
66 Tardive dyskinesia exacerbating with mania: a case report Eşel, E.
 2000
 10 Supplement 3 p. 222-223
2 p.
 artikel
67 Targeted mutation of benzodiazepine receptors: new insights into structure and function Möhler, H.
 2000
 10 Supplement 3 p. 166-167
2 p.
 artikel
68 The effect of fluoxetine and imipramine on c-fos expression induced by immobilization stress Kim, K.S.
 2000
 10 Supplement 3 p. 404-
1 p.
 artikel
69 The effect of quetiapine in improving cognitive impairment in schizophrenia Hellewell, J.S.E.
 2000
 10 Supplement 3 p. 300-301
2 p.
 artikel
70 The role of the balance system in panic disorder Perna, G.
 2000
 10 Supplement 3 p. 346-
1 p.
 artikel
71 The treatment of depression in the psychiatric practice in Switzerland: a survey study Delini-Stula, A.
 2000
 10 Supplement 3 p. 229-230
2 p.
 artikel
72 The use of atypical antipsychotics in the university psychiatric hospital in Athens Kontaxakis, V.P.
 2000
 10 Supplement 3 p. 313-314
2 p.
 artikel
73 The use of citalopram in resistant OCD Marazziti, D.
 2000
 10 Supplement 3 p. 352-353
2 p.
 artikel
74 Treatment for Alzheimer's disease — where are we going? Wilcock, G.K.
 2000
 10 Supplement 3 p. 140-141
2 p.
 artikel
75 Treatment of depression and concomitant anxiety Nutt, David
 2000
 10 Supplement 3 p. S433-S437
5 p.
 artikel
76 Treatment of psychiatric symptoms in epilepsy Krämer, G.
 2000
 10 Supplement 3 p. 115-116
2 p.
 artikel
77 Weight gain during treatment with mirtazapine goes along with an increase in plasma levels of cytokines and leptin Kraus, T.
 2000
 10 Supplement 3 p. 272-273
2 p.
 artikel
                             77 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland